(Q79972356)
Statements
Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy (English)
Noriaki Sunaga
Yoshio Tomizawa
Noriko Yanagitani
Hironobu Iijima
Kyoichi Kaira
Kimihiro Shimizu
Shigebumi Tanaka
Tatsuo Suga
Takeshi Hisada
Tamotsu Ishizuka
Ryusei Saito
Kunio Dobashi